For example, younger females are more susceptible to develop metabolic diseases than males due to difference in insulin sensitivity and glucose disposal ability (especially diabetes and its comorbidities) [167,168], while this tendency switches after the age of 40, potentiating the critical role of sexual hormones in controlling insulin signaling [169]. This evidence concerns the gene INS and metabolic disease.